|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- NHS Trusts (England) - Chief Executive
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- NHS Trusts (England) - Medical Director
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Director of Public Health
|
Action category: |
|
Class 2: Action within 48 hours
|
Title: |
|
DRUG ALERT CLASS 2, ACTION WITHIN 48 HOURS, DR. REDDY'S LABORATORIES LTD, ARIPIPRAZOLE 1MG/ML ORAL SOLUTION
|
Broadcast content: |
|
Dr. Reddy's Laboratories (UK) Ltd is recalling one batch of the above product because there is the potential for small particles of Aripiprazole active substance to be present.
Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts
|
Cascade to: |
|
- #GP#
- #COMMUNITYPHARMACISTS#
- #DISPENSING GP#
- #HospitalPharmacy#
|